# PharmaCyte Biotech (PMCB) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/PMCB
## Company Profile
- Ticker: PMCB
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology, Cardio-Metabolic
## Stock Data
- Close: 0.4913 USD
- Market cap: 8064619.5287999995 USD
- Last updated: 2026-09-03
## Business Overview
PharmaCyte Biotech was a biotechnology company focused on cell encapsulation and oncology before its restructuring and public-market decline. Its story centered on an experimental cancer-delivery platform.
## Why The Stock Is Moving

As of Sep 3, 2026, PMCB closed up 2.21% at $0.4913. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ before restructuring, PharmaCyte sat in specialty biotechnology.

## Business Model

The business depended on clinical validation, platform feasibility, and the chance to convert a niche concept into value.

## Landscape Position

PharmaCyte belongs to the historical or restructuring biotech set rather than the current live public-company universe.

## Future Catalysts

- PharmaCyte is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is focused on what value remains.

## Recent News
- 2025-11-25 14:15 EST — [PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-successfully-monetizes-femasys-stake-strengthening-cash-position-and-underscoring-strategic-capital-deployment) — Source: PharmaCyte Biotech
- 2025-09-02 13:20 EST — [PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-increases-stake-in-tnf-pharmaceuticals-around-recent-license-for-breakthrough-light-speed-computing-platform-for-use-in-cryptocurrency-applications) — Source: PharmaCyte Biotech
- 2025-08-20 13:15 EST — [PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-announces-closing-of-7-million-financing) — Source: PharmaCyte Biotech
- 2025-08-18 13:15 EST — [PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-announces-7-million-capital-raise-led-by-existing-investors) — Source: PharmaCyte Biotech
- 2024-05-21 13:00 EST — [PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-makes-7-million-strategic-investment-in-mymd-a-biopharmaceutical-company-focused-on-inflammatory-disease) — Source: PharmaCyte Biotech